Antuamwine, BB, Bosnjakovic, R, Hofmann-Vega, F, Wang, X, Theodosiou T, Iliopoulos, I, Brandau, S. N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2022; 00: 1- 30. doi:10.1111/imr.13176
COST (European Cooperation in Science and Technology)
The work from the COST Action 20117 - Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (Mye-InfoBank) is supported by COST (European Cooperation in Science and Technology).
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.